TRIUS THERAPEUTICS INC's ticker is TSRX and the CUSIP is 89685K100. A total of 7 filers reported holding TRIUS THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2013 | $483,000 | – | 59,626 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 1,099,700 | $8,906,000 | 2.76% |
| Broadfin Capital, LLC | 404,427 | $3,276,000 | 0.64% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 56,300 | $457,000 | 0.62% |
| EAM Investors, LLC | 270,881 | $2,200,000 | 0.48% |
| West Family Investments, Inc. | 110,424 | $894,000 | 0.24% |
| SHEPHERD KAPLAN KROCHUK, LLC | 138,811 | $1,124,000 | 0.22% |
| BB BIOTECH AG | 280,000 | $2,268,000 | 0.16% |
| Benin Management CORP | 30,000 | $243,000 | 0.15% |
| Loeb Offshore Management LP | 26,900 | $218,000 | 0.11% |
| TFS CAPITAL LLC | 235,592 | $1,908,000 | 0.08% |